<DOC>
	<DOCNO>NCT00925327</DOCNO>
	<brief_summary>This compassionate treatment protocol use UV-X system corneal collagen cross-linking ( CXL ) eye progressive keratoconus patient condition limit capacity comply cross-linking treatment procedure require ongoing clinical trial .</brief_summary>
	<brief_title>Safety Effectiveness UV-X System Corneal Collagen Cross-Linking Compassionate Treatment Pediatric Patients With Progressive Keratoconus</brief_title>
	<detailed_description>This non-randomized study . All eye qualify study receive cross-linking ( CXL ) procedure . Corneal collagen cross-linking perform single treatment . Depending patient 's condition , CXL procedure may perform sedation anesthesia . Subjects follow 12 month procedure evaluate long term effect corneal collagen cross-linking .</detailed_description>
	<mesh_term>Keratoconus</mesh_term>
	<mesh_term>Riboflavin</mesh_term>
	<criteria>Age 6 18 year Having diagnosis progressive keratoconus Signed write inform consent Having condition limit patient 's capacity comply crosslinking treatment procedure and/or diagnostic test measurement require ongoing clinical study Willingness ability comply schedule followup visit Corneal pachymetry screen exam &lt; 400 micron thinnest point Previous ocular condition eye ( ) treat may predispose eye future complication , example ( herpes simplex , herpes zoster keratitis , recurrent erosion syndrome , corneal melt , corneal dystrophy , etc . ) A history delay epithelial healing eye ( ) treat Pregnancy lactation course study A known sensitivity study medication</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>June 2009</verification_date>
</DOC>